The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of common stock on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $40.034 (individual trade prices ranged from $39.65 to $40.22). After the sale he beneficially owned 623,866 shares. The filing also discloses a fully vested, currently exercisable non-qualified stock option covering 27,300 underlying shares with a $10.178 exercise price. The Form 4 was filed by an attorney-in-fact on behalf of the reporting person and identifies the sale as pre-arranged under Rule 10b5-1.
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.
Insider sale under a Rule 10b5-1 plan: Liran Ira, a director of Vita Coco Company, Inc. (COCO), reported selling 50,000 shares of the issuer's common stock on 09/17/2025 at a weighted average price of $42.003 per share. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. After the reported transactions, the form discloses 598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth exercised non-qualified stock options for 16,827 shares of common stock at $10.1780 per share on September 17, 2025, then sold the same 16,827 shares at a weighted average price of $42.5460 under a Rule 10b5-1 trading plan, with sales between $42.50 and $42.73. Following these transactions, he directly holds 76,127 shares of common stock and 426,265 non-qualified stock options.
Verlinvest Beverages SA, reporting as an officer of Vita Coco Company, Inc. (COCO), sold 3,000,000 shares of the issuer's common stock on 09/17/2025 at a price of $40.77 per share. The filing lists 4,097,161 shares beneficially owned following the transaction, held directly. The sale is described as a block sale executed under Rule 144 to an unaffiliated financial institution. The Form 4 is signed by Axelle Henry on 09/19/2025 and indicates the reporting person is a former 10% owner and an officer.
Martin Roper, a director and the CEO of Vita Coco Company, Inc. (COCO), reported multiple sales of common stock on September 16–17, 2025 effected under a Rule 10b5-1 trading plan. The Form 4 shows both direct and indirect dispositions: direct sales by the reporting person and sales of shares held in related family trusts. Prices reported are weighted averages around $40.00–$40.54 per share. The filing also discloses substantial stock option holdings that are largely vested and exercisable at strike prices ranging from $10.178 to $32.78, with multiple option grants representing significant potential common shares.
Corey Baker, listed as Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported a series of transactions on 09/16/2025–09/18/2025. The filings show three separate acquisitions of 1,000 shares each at $16.91 and three corresponding sales of 1,000 shares each at $40. After those transactions the reporting person held 38,754 shares of common stock.
The Form 4 also discloses exercises or holdings of multiple non-qualified stock options with strike prices ranging from $16.91 to $33.36 covering in aggregate thousands of underlying shares (for example, 13,481 shares at $24.35 and 13,218 shares at $33.36). The sales of common stock were effected pursuant to a Rule 10b5-1 trading plan, as stated in the filing.
Form 144 notice filed for Vita Coco Company, Inc. (COCO). The filer intends to sell 3,000,000 shares of common stock through Morgan Stanley & Co. LLC on or about 09/17/2025, with an aggregate market value of $126,900,000. The shares were acquired on 12/21/2016 via a pre-IPO investment originally held by Verlinvest SA and later transferred to Verlinvest Beverages SA; payment was in cash. The issuer has 56,822,981 shares outstanding per the filing. The notice states there were no securities sold by the reporting person in the past three months and includes the required representation that the selling person is not aware of undisclosed material adverse information.
Vita Coco Company, Inc. (COCO) filed a Form 144 reporting proposed sale of 20,000 common shares following an exercise of stock options on the same day. The securities are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value reported as $799,600 and approximately 56,822,981 shares outstanding. The filer reports the acquisition and payment occurred on 09/17/2025 (cash payment), and discloses a recent 10b5-1 sale of 10,000 shares on 09/12/2025 generating $400,032 in gross proceeds. The filing includes the usual representation about absence of undisclosed material information.